Oracle Health Sciences
has strengthened its analytics offerings with the release of
Oracle® Clinical Development Analytics 2.0
and
Oracle Life Sciences Data Hub 2.1.4
.
Oracle’s life sciences analytics solutions help organizations accelerate insight and increase research and development efficiency. Oracle Clinical Development Analytics 2.0 expands beyond the product’s original focus on clinical data management to provide rich content for clinical operations.
With more than 360 pre-built and pre-sourced metrics and associated attributes, Oracle Clinical Development Analytics 2.0 enables life sciences organizations to gain insight into trial and program performance and make more informed business decisions by helping them to:
For comprehensive insight across the clinical trial environment, Oracle Clinical Development Analytics 2.0 now sources data directly from Oracle’s Siebel Clinical Trial Management System, in addition to information from Oracle Clinical and Oracle Remote Data Capture.
Oracle Life Sciences Data Hub 2.1.4 is a validated and secure data repository that integrates clinical, non-clinical and safety data from multiple sources into a unified environment. This helps enable organizations to streamline business processes around trial data acquisition, analysis and reporting. Updates to the latest version help:
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.